NIH-funded research R01 grant

Preventing lymphedema in breast cancer patients through immediate lymphatic reconstruction

Official title: Lymphedema Prevention Through Immediate Lymphatic Reconstruction

Funded at University of Tx Md Anderson Can Ctr · NIH-10942914 · Data updated 2026-11-12

This study is looking at a new surgery called immediate lymphatic reconstruction to help prevent painful swelling, known as lymphedema, in women with inflammatory breast cancer who are at higher risk after their treatment.

More Lymphedema research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startAugust 1, 2024
Project endJuly 31, 2029
Funding year2024
Award (this year)$516,114
NIH project number1R01CA292908-01
Project IDNIH-10942914 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with inflammatory breast cancer who are scheduled for axillary lymphadenectomy.

Less likely to help

Patients who do not have inflammatory breast cancer or who are not undergoing axillary lymphadenectomy may not benefit from this research.

What this research studies

This research investigates a surgical approach called immediate lymphatic reconstruction (ILR) to prevent lymphedema in patients with inflammatory breast cancer (IBC). IBC patients often undergo aggressive treatments that increase their risk of developing lymphedema, a condition that causes painful swelling. The study aims to assess the effectiveness of ILR performed during axillary lymphadenectomy to reduce the incidence of lymphedema and improve patient outcomes. By focusing on this high-risk group, the research seeks to identify biomarkers and evaluate long-term results of the procedure.

Why it matters

Potential benefit: If successful, this research could significantly reduce the incidence of lymphedema in breast cancer patients, enhancing their quality of life.

How similar studies have gone: Previous studies have shown promising results with immediate lymphatic reconstruction in other breast cancer populations, but this specific approach for IBC patients is novel.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Schaverien, Mark V — University of Tx Md Anderson Can Ctr
  • Study coordinator: Schaverien, Mark V

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.